TY - JOUR
T1 - Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis
AU - Ramacciotti, Eduardo
AU - Blackburn, Susan
AU - Hawley, Angela E.
AU - Vandy, Frank
AU - Ballard-Lipka, Nicole
AU - Stabler, Cathy
AU - Baker, Nichole
AU - Guire, Kenneth E.
AU - Rectenwald, John E.
AU - Henke, Peter K.
AU - Myers, Daniel D.
AU - Wakefield, Thomas W.
PY - 2011/8
Y1 - 2011/8
N2 - Objective: The combination of D-dimer and Wells score can exclude, but not confirm, the diagnosis of deep venous thrombosis (DVT). Since thrombosis and inflammation are interrelated, we evaluated the combination of soluble P-selectin (sPsel) with other inflammatory biomarkers for the diagnosis of DVT. Methods: Sixty-two positive and one hundred and sixteen patients with negative DVT, by duplex scan, were prospectively evaluated for sPsel, D-dimer, C-reactive protein (CRP), microparticles (MPs; total, leukocyte, and platelet-derived and tissue factor positive microparticles), and clinical Wells score. Results: Biomarkers and clinical scores that differentiated DVT positives from negatives were sPsel (87.3 vs 53.4 ng/mL, P <.0001), D-dimer (5.8 vs 2.1 mg/ L, P <.0001), CRP (2.1 vs 0.8 μg/mL, P <.0005), and Wells score (3.2 vs 2.0, P <.0001). For MP analysis, platelet-derived MPs were found to differentiate DVT from negatives. Using multivariable logistic regression, a combination of sPsel and Wells score could establish the diagnosis of DVT (cut point ≥90 ng/mL + Wells ≥2), with a specificity of 96% and positive predictive value (PPV) of 100%, and could exclude DVT diagnosis (cut point ≤60 ng/mL and Wells <2) with a sensitivity of 99%, a specificity of 33%, and a negative predictive value (NPV) of 96%. Conclusion: This study establishes a biomarker and clinical profile combination that can both confirm and exclude the diagnosis of DVT.
AB - Objective: The combination of D-dimer and Wells score can exclude, but not confirm, the diagnosis of deep venous thrombosis (DVT). Since thrombosis and inflammation are interrelated, we evaluated the combination of soluble P-selectin (sPsel) with other inflammatory biomarkers for the diagnosis of DVT. Methods: Sixty-two positive and one hundred and sixteen patients with negative DVT, by duplex scan, were prospectively evaluated for sPsel, D-dimer, C-reactive protein (CRP), microparticles (MPs; total, leukocyte, and platelet-derived and tissue factor positive microparticles), and clinical Wells score. Results: Biomarkers and clinical scores that differentiated DVT positives from negatives were sPsel (87.3 vs 53.4 ng/mL, P <.0001), D-dimer (5.8 vs 2.1 mg/ L, P <.0001), CRP (2.1 vs 0.8 μg/mL, P <.0005), and Wells score (3.2 vs 2.0, P <.0001). For MP analysis, platelet-derived MPs were found to differentiate DVT from negatives. Using multivariable logistic regression, a combination of sPsel and Wells score could establish the diagnosis of DVT (cut point ≥90 ng/mL + Wells ≥2), with a specificity of 96% and positive predictive value (PPV) of 100%, and could exclude DVT diagnosis (cut point ≤60 ng/mL and Wells <2) with a sensitivity of 99%, a specificity of 33%, and a negative predictive value (NPV) of 96%. Conclusion: This study establishes a biomarker and clinical profile combination that can both confirm and exclude the diagnosis of DVT.
KW - deep venous thrombosis
KW - thrombosis
KW - venous thromboembolism
UR - http://www.scopus.com/inward/record.url?scp=80052769533&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052769533&partnerID=8YFLogxK
U2 - 10.1177/1076029611405032
DO - 10.1177/1076029611405032
M3 - Article
C2 - 21593019
AN - SCOPUS:80052769533
SN - 1076-0296
VL - 17
SP - 425
EP - 431
JO - Clinical and Applied Thrombosis/Hemostasis
JF - Clinical and Applied Thrombosis/Hemostasis
IS - 4
ER -